Company / Return on Equity (ROE)
MARAVAI LIFESCIENCES HOLDINGS, INC. Return on Equity (ROE) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-61.6%
FY2025
5-year range
-61.6% / 57.7%
FY2021-FY2025
Trend
-38.3%
vs FY2024
Sector context
#149 of 190
Health Care
What the data says
MARAVAI LIFESCIENCES HOLDINGS, INC. reports negative total equity of -61.6% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-61.6% in FY2025 with a 5-year CAGR of -119.1%.
Declined from -28.6% to -61.6% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -102.0pp
- 5-Year Change
- -119.1pp
- 10-Year Change
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 190This company -61.6% Sector average -50.3%
▼
-22.4% below sector average
Key checks
Key Insights
- MARAVAI LIFESCIENCES HOLDINGS, INC.'s return on equity (roe) has declined for 4 consecutive years.
- In FY2025, return on equity (roe) decreased 38.3% year-over-year.
- Currently 11.3pp below the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -61.6% | -38.3% |
| FY2024 | -44.5% | -55.9% |
| FY2023 | -28.6% | -170.7% |
| FY2022 | 40.4% | -30.0% |
| FY2021 | 57.7% | +0.3% |
| FY2020 | 57.5% | +1960.8% |
| FY2019 | -3.1% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026